Close Menu

Quest

Data Breach at Quest

Almost 12 million Quest Diagnostics customers may have had their personal information exposed in a data breach, CNBC reports.

A study of 10 commercial labs offering NIPT in the US found that none followed all recommendations for reporting results and informing patients and providers.

The development is a positive for plaintiff Amy Williams, who has said she hopes her lawsuit will spur greater accountability and transparency among genetic testing labs.

The groups will conduct a study evaluating the benefits of targeted next-generation sequencing in the diagnosis and care of infants with genetic disorders.

Case Continues

The Post and Courier discusses a South Carolina court's decision in the Williams v Quest case.

One woman affected by Ireland's cervical cancer scandal has settled with the Irish health service and US-based Quest Diagnostics.

Though the South Carolina Supreme Court said Quest was a healthcare provider, Williams can try to keep her case alive by arguing she's alleging ordinary negligence.

The court's ruling that Quest was acting as a licensed healthcare provider could affect the statute of limitations in the suit.

The prospective analysis suggests that the approach could help clinicians identify patients at risk of a stroke who could benefit from anticoagulant treatment.

The companies are accelerating the pace of an existing collaboration with the goal of detecting SMA "2+0" carrier status.

Pages

NPR says the explosion and fire earlier this week at a Russian lab that stores dangerous pathogens revives the question of whether such samples should be kept.

According to Wired, Nebula Genomics is providing a way for people to get their genomes sequenced anonymously.

A 26-year-old woman tells Cosmopolitan about learning her APOE status at a young age.

In Science journals this week: a functional genomic screen uncovers drug combination that increases KRAS inhibitor efficacy in aggressive lung cancer, and more.